Moreover, in response to thermal doses of PBNP-PTT, GD2 expression was significantly increased on the surface of SH-SY5Y cells, which provides important information regarding the potential of anti-GD2 immunotherapy-based combination therapy with PBNP-PTT for the treatment of NB without MYCN amplification. The gene discussed is MYCN; the disease is neuroblastoma.